Ph.D., Mercer University
M.S., Campbell University
B.S., Mumbai University
Dr. Chablani comes to the Department of Pharmaceutical Sciences with a B.S in Pharmacy from University of Mumbai, India. After completion of her B.S. in Pharmacy, she moved on to pursue a Master’s degree at Campbell University, School of Pharmacy and Health Sciences, North Carolina. During her Master’s program she worked with the Research and Development team of GlaxoSmithKline (NC) to evaluate two Process Analytical Tools (PATs) to optimize granulation process for tablet manufacturing. She has successfully published a research paper in AAPS PharmSciTech journal on this collaborative thesis work. Dr. Chablani further graduated with a Ph.D. in Pharmaceutical Sciences from Mercer University College of Pharmacy and Health Sciences. Her Ph.D. dissertation was focused on formulation and evaluation of particulate breast cancer vaccines. Dr. Chablani owns publications in distinguished journals for her research work at Mercer University. She also completed the ACPE accredited Pharmacy Teaching Certificate program from Mercer University.
Dr. Chablani is involved in co-teaching following courses at Wegmans School of Pharmacy:
- PHAR 3240 – Biosystems I
- PHAR 3142 – Pharmaceutics I
- PHAR 3242 – Pharmaceutics II
- PHAR 4112 – Applied Pharmaceutics I (Course- coordinator)
- PHAR 5510 – Independent Research Elective
- PHAR 5515 – Applied Extemporaneous Compounding I (Course-Coordinator)
- PHAR 5516 – Pharmaceutical Biotechnology Elective (Course-Coordinator
Along with teaching, Dr. Chablani has an active research laboratory focused on drug delivery systems, vaccines and cancer immunology. Dr. Chablani’s past and present research collaborations include Abbott Pharmaceuticals (IL), GlaxoSmithKline (NC), Bausch and Lomb (NY), iuvo BioSciences (NY), Pharmanza Herbals (India) and Emory University (GA). Dr. Chablani is also an active member of AAPS, AACP, Rho Chi and Phi Kappa Phi.
- SA Tawde, L Chablani, A Akalkotkar and MJ D’Souza. Evaluation of Microparticulate Ovarian Cancer Vaccine via Transdermal Route of Delivery. Journal of Controlled Release. 2016 May 26. pii: S0168-3659(16)30348-0.
- L Chablani and V Kumar. Nanovesicular carrier system for Ophthalmic Drug Delivery. Nano-Bio Materials for Ophthalmic Drug Delivery, Springer. 2016 (In press)
- L Kratochwill, E Almagambetova, A Corigliano, C Birnie and L Chablani. The Use of Podcast as a Teaching Tool for a Pharmacy Compounding Pre-Laboratory Lecture: A Survey based Study. Pharmacy Education, 2016; 16 (1), 37-41.
- A Akalkotkar, L Chablani, SA Tawde and MJ D’Souza. Development of a microparticulate prostate cancer vaccine and evaluating the effect of route of administration on its efficacy via the Skin. Journal of Microencapsulation. 2015; May 19:1-9. PMID: 25985824
- L Chablani, N Mulla and D’Souza MJ. Mucosal delivery of particulate breast cancer vaccine. Nanoparticulate Vaccine Delivery Systems, Pan Stanford Publishing. 2015; May: 171-185.
- L Chablani, MJ D’Souza, SA Tawde, A Akalkotkar, M D’Souza and M Chiriva-Internati. Nanotechnology in Vaccine Delivery. Molecular Vaccines, 2014 Volume 2: 727-741.
- L Chablani, SA Tawde, A Akalkotkar, C D’Souza, P Selvaraj and MJ D’Souza. Formulation and evaluation of a particulate oral breast cancer vaccine. J Pharm Sci 2012 Oct; 101(10):3661-71. PMID: 22828873
- SA Tawde, L Chablani, A Akalkotkar, M Chiriva-Internati, C D’Souza, P Selvaraj and MJ D’Souza Formulation and evaluation of oral microparticulate ovarian cancer vaccines. Vaccine 2012 Aug 17; 30(38):5675-81. PMID: 22750042
- A Akalkotkar, SA Tawde, L Chablani and MJ D’Souza. Oral delivery of particulate prostate cancer vaccine: in vitro and in vivo evaluation. J Drug Target. 2012 May; 20(4):338-46. PMID: 22296308
- L Chablani, SA Tawde and MJ D’Souza. Spray-dried microparticles: a potential vehicle for oral delivery of vaccines. J Microencapsul. 2012; 29(4):388-97. PMID: 22283700
- L Chablani, MK Taylor, A Mehrotra, P Rameas and WC Stagner. Inline real-time near-infrared granule moisture measurements of a continuous granulation-drying-milling process. AAPS PharmSciTech. 2011 Dec; 12(4):1050-5. PMID: 21842310